美国国债抛售的连锁反应:从价格下跌到财政困局

Kairos Therapeutics

company

About

Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.

  • 51 - 100

Details

Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Close